Chemical formula: C₁₃H₁₈Br₂N₂O Molecular mass: 378.108 g/mol PubChem compound: 2132
Ambroxol is indicated for:
Population group: only adolescents (12 years - 18 years old) , adults (18 - 65 years old)
Ambroxol is indicated for mucolytic therapy of productive cough associated with acute or chronic bronchopulmonary diseases.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old)
Ambroxol is indicated for mucolytic therapy of productive cough associated with acute or chronic bronchopulmonary diseases.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Ambroxol is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
